Table 1.
Indication | HLA-Matched Related Donor | Alternative Donor* | |
---|---|---|---|
Predictors for Increased Mortality | ≥2 VOC/year | X | X |
Recurrent acute chest syndrome | X | X | |
Stroke | X | X | |
Cognitive impairment + Abnormal cerebral MRI | X | X | |
TRJV ≥ 2.7 m/s | X | X | |
Sickle nephropathy | X | ||
Predictors for Increased Morbidity | Red blood cell alloimmunization | X | |
Recurrent priapism | X | ||
Osteonecrosis of multiple joints | X |
HLA, human leukocyte antigen; VOC, vaso-occlusive crisis; MRI, magnetic resonance imaging: TRJV, tricuspid regurgitant jet velocity. * Despite hydroxyurea and/or chronic red blood cell transfusion therapy.